NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
EYEDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/11/2024
Trademark type
Word
Nice classes
9, 42
Filing date
05/04/2023
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Paris, FR
Examiner
ADEJUNMOBI, AKIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
T. H. (pessoa física)
Representatives
PINA CAMPAGNA CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Recorded and downloadable computer programs for accessingbrowsing and searching online clinicalpathologymolecular biology databases; Electronic database in the field of clinicalpathology and molecular biology recorded on computer media; Recorded and downloadable software for managinganalysingprocessing and sharing clinical data and medical images; Recorded and downloadable software for image consultationfile transmissionsearching within clinicalpathologymolecular biology databases; Recorded and downloadable software for the visualisationdistribution and communication of medical images and clinical data; Recorded and downloadable software for management of pathology images; Recorded and downloadable software for data management and database searching for patient identificationpatient stratificationselection of investigator centres for preclinicaltranslational and clinical research; Recorded and downloadable software for conducting medical and scientific research; Recorded and downloadable software for clinical trial research including oncology clinical trials; Recorded and downloadable software for clinical trial research using artificial intelligence and data science technology; Recorded and downloadable software for interpretation of pathology data and images for analysisdiagnosis and prognosis of multimodal medical imaging for personalised medicine
Class 42
Medical research services related to the treatment of patients; Conceptiondevelopment and maintenance of software for managinganalysingprocessing and sharing clinical data and medical images; Conceptiondevelopment and maintenance of software for image consultationfile transmissionsearching within clinicalpathology and molecular biology databases; Conceptiondevelopment and maintenance of integrated software for the visualisationdistribution and communication of medical images and clinical data; Conceptiondevelopment and maintenance of pathology image management software; Conception of clinicalpathology and molecular biology databases; data analysis and electronic storage of scientificclinicalpathology and molecular biology data; Conceptiondevelopment and maintenance of data management and database search software for patient identificationpatient stratificationselection of investigator centres for preclinicaltranslational and clinical research; Conceptiondevelopment and maintenance of software for medical and scientific research; Conceptiondevelopment and maintenance of software for clinical trial research including oncology clinical trials; Conceptiondevelopment and maintenance of software for clinical trial research using artificial intelligence and data science technology; Conceptiondevelopment and maintenance of medical software for interpretation of pathology data and images for analysisdiagnosis and prognosis of multimodal medical imaging for personalised medicine; Computerised data analysis services for patient identificationpatient stratificationselection of investigator centres for preclinicaltranslational and clinical research; Medical and scientific research in the field of medical imaging; Conception and development of medical technologies in the field of cancerinflammatory and rare diseases therapeutics developmentdiagnostics and theragnostics; Conception and development of medical diagnostic devices in the field of cancerinflammatory and rare diseases; Provision of medical and scientific research information in the field of clinical trials; Medical research; Biologicalclinical and medical research; Scientific research for medical purposes in the field of cancerinflammatory and rare diseases therapeutics developmentdiagnostics and theragnostics; Computer graphics services; computer serviceselectronic digitizing of images; Computer data analysis services in the field of medical imaging
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/16/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2024
DOCK
ASSIGNED TO EXAMINER
01/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2023
NWAP
NEW APPLICATION ENTERED
05/08/2023
Continuous trademark protection
Get notified about every new filing that threatens EYEDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.